Cargando…
Ruptured Hepatocellular Carcinoma: What Do Interventional Radiologists Need to Know?
Rupture of HCC (rHCC) is a life-threatening complication of hepatocellular carcinoma (HCC), and rHCC may lead to a high rate of peritoneal dissemination and affect survival negatively. Treatment for rHCC mainly includes emergency surgery, interventional therapies, and palliative treatment. However,...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243354/ https://www.ncbi.nlm.nih.gov/pubmed/35785181 http://dx.doi.org/10.3389/fonc.2022.927123 |
_version_ | 1784738288013148160 |
---|---|
author | Yan, Jingxin Li, Ting Deng, Manjun Fan, Haining |
author_facet | Yan, Jingxin Li, Ting Deng, Manjun Fan, Haining |
author_sort | Yan, Jingxin |
collection | PubMed |
description | Rupture of HCC (rHCC) is a life-threatening complication of hepatocellular carcinoma (HCC), and rHCC may lead to a high rate of peritoneal dissemination and affect survival negatively. Treatment for rHCC mainly includes emergency surgery, interventional therapies, and palliative treatment. However, the management of rHCC should be carefully evaluated. For patients with severe bleeding, who are not tolerant to open surgery, quick hemostatic methods such as rupture tissue ablation and TAE/TACE can be performed. We described clinical presentation, prognosis, complication, interventional management, and current evidence of rHCC from the perspective of interventional radiologists. Overall, our review summarized that interventional therapies are necessary for most patients with rHCC to achieve hemostasis, even in some patients with Child–Pugh C. Moreover, TAE/TACE followed by staged hepatectomy is a beneficial treatment for rHCC according to current clinical evidence. TAE/TACE is the first choice for most patients with rHCC, and appropriate interventional treatment may provide staged surgery opportunities for those who are not tolerant to emergency surgery to reach an ideal prognosis. |
format | Online Article Text |
id | pubmed-9243354 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92433542022-07-01 Ruptured Hepatocellular Carcinoma: What Do Interventional Radiologists Need to Know? Yan, Jingxin Li, Ting Deng, Manjun Fan, Haining Front Oncol Oncology Rupture of HCC (rHCC) is a life-threatening complication of hepatocellular carcinoma (HCC), and rHCC may lead to a high rate of peritoneal dissemination and affect survival negatively. Treatment for rHCC mainly includes emergency surgery, interventional therapies, and palliative treatment. However, the management of rHCC should be carefully evaluated. For patients with severe bleeding, who are not tolerant to open surgery, quick hemostatic methods such as rupture tissue ablation and TAE/TACE can be performed. We described clinical presentation, prognosis, complication, interventional management, and current evidence of rHCC from the perspective of interventional radiologists. Overall, our review summarized that interventional therapies are necessary for most patients with rHCC to achieve hemostasis, even in some patients with Child–Pugh C. Moreover, TAE/TACE followed by staged hepatectomy is a beneficial treatment for rHCC according to current clinical evidence. TAE/TACE is the first choice for most patients with rHCC, and appropriate interventional treatment may provide staged surgery opportunities for those who are not tolerant to emergency surgery to reach an ideal prognosis. Frontiers Media S.A. 2022-06-16 /pmc/articles/PMC9243354/ /pubmed/35785181 http://dx.doi.org/10.3389/fonc.2022.927123 Text en Copyright © 2022 Yan, Li, Deng and Fan https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Yan, Jingxin Li, Ting Deng, Manjun Fan, Haining Ruptured Hepatocellular Carcinoma: What Do Interventional Radiologists Need to Know? |
title | Ruptured Hepatocellular Carcinoma: What Do Interventional Radiologists Need to Know? |
title_full | Ruptured Hepatocellular Carcinoma: What Do Interventional Radiologists Need to Know? |
title_fullStr | Ruptured Hepatocellular Carcinoma: What Do Interventional Radiologists Need to Know? |
title_full_unstemmed | Ruptured Hepatocellular Carcinoma: What Do Interventional Radiologists Need to Know? |
title_short | Ruptured Hepatocellular Carcinoma: What Do Interventional Radiologists Need to Know? |
title_sort | ruptured hepatocellular carcinoma: what do interventional radiologists need to know? |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243354/ https://www.ncbi.nlm.nih.gov/pubmed/35785181 http://dx.doi.org/10.3389/fonc.2022.927123 |
work_keys_str_mv | AT yanjingxin rupturedhepatocellularcarcinomawhatdointerventionalradiologistsneedtoknow AT liting rupturedhepatocellularcarcinomawhatdointerventionalradiologistsneedtoknow AT dengmanjun rupturedhepatocellularcarcinomawhatdointerventionalradiologistsneedtoknow AT fanhaining rupturedhepatocellularcarcinomawhatdointerventionalradiologistsneedtoknow |